•  
• Experience of conducting large international cross-country observational/clinical trials
• Experience of liasing with investigators and organising studies in developing countries

  Past Commitments

   

  • Consultant in Diabetes and Metabolism The Royal Oldham Hospital; The Pennine Acute Hospitals NHS Trust
  • Professor University of Salford
  • Local lead for Diabetes at The Royal Oldham Hospital
  • Member Executive Committee Greater Manchester Comprehensive Local Research Network
  • Member Steering Committee, Diabetes & Obesity Research Network, Greater Manchester
  • Member laboratory sub-committee HEART UK
  • Associate Editor. Annals of Clinical Biochemistry
• Director of Research & Development, The Pennine Acute NHS Hospitals Trust
• Member, North West Clinical Trials Mapping Project
• Member R&D Committee, Oldham Primary Care Trust
• Member Greater Manchester Strategic Health Authority Point of Care Testing pilot
• Commanding Officer, 207 (Manchester) Field Hospital RAMC, 2004-2007
• Consultant Physician, Joint Force Medical Group, Afghanistan, 2007 & 2010-2011
• Commanding Officer, British Army UK Medical Group, Iraq, Jun-Aug 2004
• Administrative Head, Department of Clinical Biochemistry. The Royal Oldham Hospital 1995-2004
• Chairman, Oldham Research and Ethics Committee 1999-2002
• Chairman, Oldham Local Diabetes Advisory Group 1995-2002
• Member, Clinical Ethics Committee, The Royal Oldham Hospital 2001-2002
• Research & Development Steering Group, The Royal Oldham Hospital 2000-2002
• Clinical Governance lead for Pathology, The Royal Oldham Hospital 2001-2002
• Member, National Committee British Hyperlipidaemia Association 1996-1999
• Member, Oldham Coronary Heart Disease Prevention Group 1995-1999
• Member, District Diabetes Information System sub-group 1996-1999

• Mechanisms and preventions of atherosclerosis in diabetes
• Alterations in lipid and lipoprotein metabolism in diabetes
• Diabetes and Pregnancy
• Dietary and exercise requirements of diabetes and cardiovascular disease
• Trials of new treatments for diabetes and cardiovascular disease prevention

I have access to data sets and sera from previous large-scale studies, a large patient base from a population of about a million subjects in the Pennine Acute Hospitals catchments, and potential access to Indo-Asian subjects in the Manchester area and on the Indian subcontinent.

Keywords

• Adult obesity
• Appetite Regulation/Nutrition
• Chronic disease management
• High-risk groups (eg ethnic minorities)
• Macro-vascular complications of diabetes
• Metabolic syndrome/insulin resistance
• Pregnancy

Memberhsips of Committees and Professional Bodies (member since)

American Heart Association: Arteriosclerosis section (1990)
American Diabetes Association (1995)
Association of Clinical Biochemists (1982)
British Atherosclerosis Society (elected 1999)
Diabetes UK (1990)
HEART UK (1988)
British Medical Association (1979)
European Atherosclerosis Society (elected 1999)
European Association for the Study of Diabetes (1999)
European Lipoprotein Club (1988)
 

• Basic Sciences Methods
• Case control studies
• Clinical Trials
• Cohort studies
• Quantitative
• Randomised control trials/experimental studies
• I have also had GCP/ICH training

• MBBS
• PhD
• FRCP (London)
• FRCP (Ireland)
• FRCPath
•